Skip to content

Resurgence of TB, diarrhoeal disease and malnutrition in Zimbabwe due to hyperinflation and economic collapse

High-risk HPV infection raises HIV risk at least fourfold: HPV vaccine study suggested

Lopinavir/ritonavir cost-effective first-line after single-dose nevirapine in South Africa

Once-daily Kaletra as safe and effective as twice-daily dosing

English government considering revising policy on charging foreign nationals for HIV treatment

`Test and treat` unlikely to halt Washington epidemic

Cost of ART delivery in Malawi affordable within WHO-recommended health budget

Two new analyses add to abacavir cardiovascular risk debate

DART study shows HIV treatment without lab monitoring safe, effective in Africa